0      0

AONN+ Annual 2020

SAT13 - Product Theater 8 | Overview of Immune-Related Adverse Events Caused by Immune-Checkpoint Inhibitor’s Presentation by Bristol-Myers Squibb

Nov 7, 2020 3:15pm ‐ Nov 7, 2020 4:15pm


  • Ann L. Clark, RN, MSN, CCRC, CCRP, Immuno-Oncology Clinical Liaison, BMS Oncology, US Medical

You must be logged in and own this session in order to post comments.